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Abstract 
Neurological soft signs (NSS) in motor coordination and sequencing occur in schizophrenia 
patients and are an intrinsic sign of the underlying neural dysfunctions. The present 
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longitudinal study explored the relationships among NSS, psychiatric symptoms, and 
functional outcomes in 151 Chinese patients with chronic schizophrenia across a 6-month 
period. The participants completed neurological assessments at baseline (Time 1), psychiatric 
interviews at Time 1 and 3-month follow-up (Time 2), and self-report measures on daily 
functioning at 6-month follow-up (Time 3). Two possible (combined and cascading) path 
models were examined on predicting the functional outcomes. Direct and indirect effects of 
Time 1 NSS on Time 3 functional outcomes via Time 2 psychiatric symptoms were evaluated 
using path analysis under bootstrapping. Motor coordination and sequencing NSS did not 
have significant direct effects on functional outcomes. Motor coordination NSS exerted 
significant and negative indirect effects on functional outcomes via psychiatric symptoms. 
These results contribute to a better understanding of the determinants of functional outcomes 
by showing significant indirect pathways from motor coordination NSS to functional 
outcomes via psychiatric symptoms. That motor sequencing NSS did not affect functional 
outcomes either directly or indirectly may be explained by their trait marking features.  
Keywords 
neurological deficits; disorganized symptoms; negative symptoms; daily functioning; 
mediation; path analysis 
 
1. Introduction 
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Schizophrenia is an intricate neuropsychiatric disorder associated with deficits in 
cognitive, affective, and neurological domains (R. W. Heinrichs and Zakzanis, 1998). 
Neurological soft signs (NSS), defined as subtle neurological abnormalities in sensory 
integration, motor coordination and sequencing of complex motor acts (D. W. Heinrichs and 
Buchanan, 1988), occur consistently in patients with schizophrenia (Emsley et al., 2005). A 
meta-analysis (Bachmann et al., 2014) among schizophrenia patients reveals a declining trend 
in NSS together with remission of psychopathological symptoms in remitting patients. Other 
studies (Chen et al., 2000; Prikryl et al., 2012) have found deteriorations in NSS for 
non-remitting patients with a chronic course. A recent study (Chan et al., 2016) reveals an 
abnormally flat and elevated lifespan trajectory of NSS in schizophrenia patients. These 
results suggest that NSS comprise both state- and trait-like features and vary in the clinical 
course of schizophrenia. 
Schizophrenia patients have been found to exhibit significantly more NSS than healthy 
subjects and patients with other psychiatric disorders (Chan et al., 2010; Wang et al., 2016). 
Their unaffected first-degree relatives also display higher NSS compared to healthy controls 
(Xu et al., 2016). Kong et al. (2012) have linked persistent and heightened NSS with 
progressive cerebral changes in schizophrenia patients. Given the linkage between NSS and 
genetic variants and neural abnormalities in brain regions (Zhao et al., 2014; Hirjak et al., 
2016), NSS have been suggested as a potential endophenotype for schizophrenia. The relative 
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ease of assessments of NSS implies that NSS could be used to monitor progression of the 
disorder or to identify subjects at risk to develop chronic schizophrenia. 
NSS have been advocated (Sewell et al., 2010; Chan et al., 2015; Chan et al., 2016) as 
outcome predictors of essential features of the disorder such as psychopathological severity 
and functional outcomes. Previous studies have established significant and positive 
associations between NSS and psychiatric symptoms such as positive symptoms (Chan et al., 
2010), negative symptoms (Prikryl et al., 2012; Mittal et al., 2014; Chan et al., 2015), and 
disorganized symptoms (Basso et al., 1998; Bombin et al., 2005) in schizophrenia patients. 
Both NSS and psychiatric symptoms are associated with poor functional outcomes in 
schizophrenia. NSS have been correlated with worse functional outcomes (Behere, 2013; 
Papiol et al., 2016) in the form of social functioning (Jahn et al., 2006), and global 
functioning (Peralta et al., 2014). Similarly, psychiatric symptoms have been found to 
contribute to long-term comorbidity and worse functioning (Milev et al., 2005; Chan et al., 
2015; Strassnig et al., 2015). 
Nevertheless, few researchers have simultaneously investigated the relationships among 
NSS, psychiatric symptoms, and functional outcomes in schizophrenia patients. Having a 
better understanding of these relationships is essential to devise effective interventions that 
facilitate patients’ recovery and enhance their overall functioning. Path-analytic approaches 
are preferred and suitable to explore these patterns. A meta-analysis by Ventura et al. (2009) 
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demonstrates that negative symptoms mediate the relationship between neurocognition and 
functional outcomes. Findings from other studies (Lin et al., 2013; Mehta et al., 2014) 
support such a mediating role for psychiatric symptoms. Apart from direct effects from NSS 
to functional outcomes, it is plausible that NSS might have indirect effects on functional 
outcomes through indirect pathways via psychiatric symptoms. Further research is warranted 
to elucidate the roles of NSS and psychiatric symptoms in predicting functional outcomes.  
To the best of our knowledge, no existing studies have explored the potential mediating 
role of psychiatric symptoms on the relationship between NSS and functional outcomes. The 
present longitudinal study adopted a path-analytic approach to evaluate the temporal 
relationships among NSS, psychiatric symptoms, and functional outcomes in schizophrenia 
patients across a 6-month period. Figure 1 depicts the conceptual model of the present study, 
where psychiatric (positive, negative, and disorganized) symptoms are posited as potential 
mediators of the relationships between NSS (deficits in motor coordination and motor 
sequencing) and functioning outcomes (IADL and ADL). This study examined two possible 
path models on predicting functional outcomes in schizophrenia patients – a combined model, 
comprising both direct and indirect effects of NSS on functional outcomes, and a cascading 
model, where NSS predicted functional outcomes solely by indirect effects via psychiatric 
symptoms. We hypothesized that the combined path model would provide a better fit than the 
cascading path model and that psychiatric symptoms would mediate the associations between 
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NSS and functional outcomes. 
[Insert Figure 1 about here] 
 
2. Methods 
2.1. Participants 
The present study is a secondary analysis of data from a randomized controlled trial (Ho 
et al., 2016) on the effectiveness of Tai-chi and physical exercise in schizophrenia patients. 
The study sample comprised 151 chronic schizophrenia patients recruited from a mental 
health rehabilitation complex in Hong Kong from September 2013 to January 2014. The 
patients were receiving long-term residential care in the hostel. Inclusion criteria were 
fulfillment of the DSM-IV TR criteria for schizophrenia according to a psychiatrist’s 
diagnosis, aged between 18 and 65 years, and ability to understand and speak Cantonese. 
Exclusion criteria included acute schizophrenia requiring hospitalization, presence of 
unstable schizophrenic symptoms (such as persistent withdrawal) that limit interaction in an 
assessment interview, a history of brain trauma or organic mental disorders, and presence of 
physical disabilities or severe illnesses that could impair cognitive or visuomotor functioning. 
At baseline (Time 1), the participants completed neurological assessments on NSS. They 
underwent structural clinical interviews on psychiatric symptoms at Time 1 and at 3-month 
follow-up (Time 2) from the same rater. At 6-month follow-up (Time 3), the participants 
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completed self-report measures on functional outcomes. Written informed consent was 
sought from the participants and the study protocol was approved by the institutional ethics 
committee of the University of Hong Kong (HKCTR-1453). Demographic and clinical 
information such as duration of the disorder and type of antipsychotic medications were 
obtained via medical record reviews. 
 
2.2. Assessments 
2.2.1. Neurological soft signs 
Two subscales of the Neurological Evaluation Scale (NES) (Buchanan and Heinrichs, 
1989) were used to evaluate the participants’ NSS in motor coordination and sequencing of 
complex motor acts. Compared to the Cambridge Neurological Inventory (Chen et al., 1995) 
and Heidelberg Scale (Schröder et al., 1991), the NES was widely used among longitudinal 
studies on NSS in schizophrenia (Bachmann et al., 2014). Neurological deficits for motor 
coordination consist of six items, namely, tandem walk, rapid alternating movements (for 
dominant and non-dominant hand), finger/thumb opposition (for dominant and non-dominant 
hand), and finger-to-nose test. Neurological deficits for sequencing in complex motor acts 
comprise three items, namely, fist-ring test, fist-edge-palm test, and Ozeretski test.  
Participants’ performance on each item was rated on a 3-point scale based on the number 
of mistakes they made. Each item score was summed up to produce a subscale score for 
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motor and sequencing deficits, with higher scores indicating greater levels of NSS. The 
Chinese version of the NES showed marginal internal consistency for sequencing deficit 
(Cronbach’s α = 0.59) and good internal consistency for motor deficit (α = 0.80) subscales in 
a previous study (Fong et al., 2015). In the present study, assessment of NSS was conducted 
by three professional raters who had a medical-related background and had received relevant 
trainings from a qualified psychiatrist. Both subscales displayed good inter-rater reliability 
with intraclass correlation coefficients found to be greater than 0.80.  
 
2.2.2. Psychiatric symptoms  
The Positive and Negative Syndrome Scale (Kay et al., 1987) was used to assess the 
positive, negative, and disorganized symptoms of schizophrenia exhibited by the participants 
in the past week. Sample items for the subscales include: delusions and hallucinations for 
positive symptoms (4 items), blunted affect and emotional withdrawal for negative symptoms 
(6 items), and conceptual disorganization and difficulty in abstraction for disorganized 
symptoms (3 items). Each subscale was rated on a 7-point scale (1 = absent, 7 = extreme) by 
three trained research assistants based on a 40-minute semi-structured psychiatric interview 
with the participants and information from their family members or primary care staff. Higher 
scores denote higher levels of psychiatric symptoms. The Chinese version of the scale (Jiang 
et al., 2013; Fong et al., 2015) has shown good psychometric properties in terms of reliability 
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and convergent validity. In the present study, all three subscales displayed good internal 
consistency (α = 0.81 - 0.85) at Time 1. Acceptable inter-rater reliability was found for all 
three subscales with intraclass correlation coefficients found to be greater than 0.70. 
 
2.2.3. Functional outcomes 
Functional outcomes were measured using the Activities of Daily Living index (ADL) 
(Mahoney and Barthel, 1965) and Instrumental Activities of Daily Living scale (IADL) 
(Lawton and Brody, 1969). ADL inquires 10 basic self-care tasks such as feeding, dressing, 
toilet use, and climbing stairs and IADL assesses independent living skills in five domains of 
daily life such as shopping, traveling on public transport, self-medication, and handling 
finance. Patients’ ability to perform these tasks was assessed by their self-report response 
with reference to information provided by their family members or primary care staff. The 
total score for ADL and IADL ranges from 0 to 100 and 0 to 5, respectively, with higher 
scores indicating better functional outcomes in terms of greater independence in daily 
functioning. The Chinese version of ADL (Leung et al., 2007) and IADL (Tong and Man, 
2002) have shown good test-retest reliability and internal consistency and robust convergent 
validity. In the present study, satisfactory internal consistency was found for ADL (α = 0.71) 
and IADL (α = 0.67) at Time 3. 
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2.3. Data analysis 
Univariate analyses were employed to obtain descriptive statistics and bivariate 
correlations between NSS, psychiatric symptoms, and functional outcomes in the sample. 
Path analysis was performed using Mplus version 7.3 (Muthén and Muthén, 1998-2013). This 
technique adopts structural equation modeling to examine hypothesized path models and 
analyze regression paths among multiple observed variables. In the present study, Time 1 
NSS in motor coordination and sequencing as were specified as the predictors or independent 
variables. Psychiatric (positive, negative, and disorganized) symptoms measured at Time 2 
were proposed as the mediator variables. Functional outcomes (ADL and IADL) measured at 
Time 3 were specified as the dependent variables or distal outcomes.  
We evaluated the hypothesized cascading and combined path models under the 
maximum likelihood estimator. In the cascading path model (solid lines in Figure 1), Time 1 
motor coordination and sequencing NSS were hypothesized to influence Time 3 ADL and 
IADL solely indirectly via Time 2 psychiatric symptoms. The combined path model tested the 
direct effects (additional dashed line) from Time 1 NSS to Time 3 functional outcomes. 
Potential confounding variables such as gender, age, education level, illness duration, and 
antipsychotic medication were included in both models as covariates. We also controlled for 
the autoregressive effects of Time 1 psychiatric symptoms on Time 2 psychiatric symptoms. 
Model fit was assessed via the following criteria (Hu and Bentler, 1999): insignificant χ2 
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(p > 0.05);
 
comparative fit index (CFI) and Tucker-Lewis index (TLI) ≥ 0.95; and root mean 
square error of approximation (RMSEA) and standardized root mean square residual (SRMR) 
≤ 0.05. Model comparison was based on the chi-square test and Bayesian information 
criterion (Raftery, 1995). A total of 5, 5, and 7 participants did not join the assessment at 
Time 1, Time 2, and Time 3, respectively. Instances of missing data were minimal (less than 
5.4% of cases for any variable) and were handled via the full information maximum 
likelihood method under the missing at random assumption (Little and Rubin, 1987).  
Unstandardized regression estimates and R
2
 values for the mediator and dependent 
variables are reported. Our path models tested a total of 12 indirect effects from the two NES 
subscales to ADL and IADL via the three psychiatric symptoms (such as Time 1 motor 
coordination NSS → Time 2 positive symptoms → Time 3 IADL or Time 1 motor 
sequencing NSS → Time 2 disorganized symptoms → Time 3 ADL). These indirect effects 
were estimated using bootstrapping with 5,000 computations (MacKinnon, 2008). The use of 
bootstrapping allowed for the likely non-normal distribution for the indirect effects as a 
product of two normally distributed parameters. Statistical significance of the indirect effects 
was determined by the bias-corrected bootstrap 95% confidence interval excluding zero 
(MacKinnon et al., 2004).  
 
3. Results 
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3.1. Sample characteristics 
The mean age of the study sample was 54.00 years (SD = 8.40) and 54% (n = 80) were 
men. The majority of the participants were single (71%, n = 104) with a secondary education 
level (60%, n = 88). The average illness duration was 29.9 years (SD = 9.8). The majority 
were receiving atypical antipsychotics (78%, n = 118) such as clozapine, risperidone, or 
olanzapine and nine patients (6%) were receiving no antipsychotics. Table 1 presents the 
descriptive statistics of the study variables. At Time 1, the subscale score was 1.63, 2.64, and 
2.72 for positive, negative, and disorganized symptoms, respectively, indicating negligible 
positive symptoms and mild negative and disorganized symptoms at baseline. Participants’ 
levels of psychiatric symptoms remained fairly stable over the 3-month period. At Time 3, the 
sample demonstrated good basic self-care skills and average independent living skills. 
[Insert Table 1 about here] 
3.2. Bivariate correlations 
Table 2 displays the bivariate correlations among the main study variables. NSS were 
significantly and positively linked with Time 2 psychiatric symptoms (r = 0.21 to 0.48, p < 
0.01). Repeated measures of psychiatric symptoms at Time 1 and 2 showed positive and 
significant autocorrelations (r = 0.36 to 0.42, p < 0.01). Both NSS and Time 2 psychiatric 
symptoms were negatively and significantly associated with daily functioning (r = -0.23 to 
-0.45, p < 0.01), except between Time 2 positive symptoms and IADL (r = -0.15, p > 0.05). 
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[Insert Table 2 about here] 
3.3. Path model estimates 
The cascading path model displayed a good model fit to the data: χ2 (38) = 45.11, p = 
0.20, CFI = 0.99, TLI = 0.96, RMSEA = 0.035, SRMR = 0.052, BIC = 7969. Adequate 
model fit was found for the combined path model: χ2 (34) = 41.98, p = 0.16, CFI = 0.98, TLI 
= 0.96, RMSEA = 0.039, SRMR = 0.048, BIC = 7986. The combined model did not provide 
a significantly better fit (△χ2 = 3.13, △df = 4, p = 0.54) and had a higher BIC than the 
cascading model. None of the direct effects from Time 1 NSS to Time 3 functional outcomes 
were statistically significant (B = -0.010 to -0.271, p = 0.21 – 0.82).  
Figure 2 presents the unstandardized path coefficients in the cascading path model. 
Participants who were females or more educated showed significantly fewer negative and 
disorganized symptoms at Time 1. Females also reported significantly lower levels of motor 
deficits and more Time 2 positive symptoms. Age, illness duration, and antipsychotic 
medication were not significantly associated with the study variables. Controlling for the 
positive autoregressive effects from Time 1 psychiatric symptoms, motor deficits but not 
sequencing deficits at Time 1 significantly and positively predicted Time 2 positive 
symptoms (R
2 
= 24.1%, p < 0.01), negative symptoms (R
2 
= 21.7%, p < 0.01), and 
disorganized symptoms (R
2 
= 30.7%, p < 0.01). Negative and disorganized symptoms at Time 
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2 significantly predicted Time 3 IADL (R
2 
= 19.6%, p < 0.01), whereas Time 2 positive and 
disorganized symptoms significantly predicted Time 3 ADL (R
2 
= 27.9%, p < 0.01). 
[Insert Figure 2 about here] 
3.4. Indirect effects of NSS on functional outcomes via psychiatric symptoms 
Sequencing deficits did not have a significant total indirect effect on IADL (B = -0.01, 
bootstrap 95% CI = -0.06 to 0.06) and ADL (B = -0.14, bootstrap 95% CI = -0.73 to 0.19) via 
psychiatric symptoms. Motor coordination deficits showed a significant total indirect effect 
on both IADL (B = -0.06, bootstrap 95% CI = -0.10 to -0.02) and ADL (B = -0.42, bootstrap 
95% CI = -1.18 to -0.11) via psychiatric symptoms. Table 3 lists the specific indirect effects 
from NSS to functional outcomes via positive, negative, and disorganized symptoms.  
As highlighted in bold and red in Figure 2, motor coordination deficits exerted 
significant and negative indirect effects on IADL via negative and disorganized symptoms. 
The two specific indirect effects (T1 motor deficits→T2 negative symptoms→T3 IADL and 
T1 motor deficits→T2 disorganized symptoms→T3 IADL) were not significantly different 
(difference = 0.03, BC bootstrap 95% CI = -0.02 to 0.09). Similarly, motor coordination 
deficits exerted significant and negative indirect effects on ADL via positive and disorganized 
symptoms. The two specific indirect effects (T1 motor deficits→T2 positive symptoms→T3 
ADL and T1 motor deficits→T2 disorganized symptoms→T3 ADL) were not significantly 
different (difference = 0.02, BC bootstrap 95% CI = -0.43 to 0.35). 
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[Insert Table 3 about here] 
 
4. Discussion 
The present study tested two models of determining functional outcomes using NSS and 
psychiatric symptoms in patients with chronic schizophrenia via a longitudinal path-analytic 
approach. The present study is the first to examine the temporal relationships among these 
variables and explore the mediating role of psychiatric symptoms in the relationships between 
NSS and functional outcomes. Most of the present sample were on antipsychotic medications 
and exhibited negligible to mild psychiatric symptoms at both Time 1 and 2. Consistent with 
previous findings (Arango et al., 2000; Mittal et al., 2007; Bachmann et al., 2014), NSS were 
positively correlated with psychiatric symptoms over the 3-month period. This study 
confirms the absence of associations between NSS and demographic characteristics such as 
antipsychotic medications and illness duration as suggested by existing literature (Bombin et 
al., 2005; Chan et al., 2010). 
 
4.1. Direct effects from NSS to functional outcomes 
Contrary to our hypothesis, the combined model did not provide a superior fit than the 
parsimonious cascading model. Despite the negative bivariate correlations among NSS and 
functioning outcomes, neither motor coordination nor sequencing NSS had significant direct 
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effects on ADL and IADL in the combined model. In a recent study by Bhagyavathi et al. 
(2015), the combined model provided a better fit than the cascading model in the 
relationships among cognitive deficits, residual symptoms and functional outcomes in 
schizophrenia patients. Two remarks could be made regarding our surprising result. On one 
hand, the study by Bhagyavathi et al. (2015) was based on cross-sectional data while our 
study adopted a longitudinal design. The temporal relationship between Time 1 NSS and 
Time 3 functional outcomes could conceivably be weaker across a time lag of 6 months, such 
that they could be fully mediated by Time 2 psychiatric symptoms. On the other hand, 
non-significance of the direct effects does not necessarily imply full mediation. It could 
indicate inadequate power to detect the difference between the total effect and the indirect 
effect in the present study. 
 
4.2. Indirect effects from NSS to functional outcomes via psychiatric symptoms 
Consistent with our hypothesis, Time 2 psychiatric symptoms mediated the effects of 
Time 1 motor coordination NSS on Time 3 functioning outcomes. This suggests greater 
neurological deficits in motor coordination are associated with more severe psychiatric 
symptoms which in turn predict poorer functional outcomes. Our findings resemble previous 
results in which psychiatric symptoms mediated the effects of neurocognition on functional 
outcomes (Ventura et al., 2009; Green et al., 2012; Bhagyavathi et al., 2015). However, motor 
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sequencing NSS did not have any significant (direct or indirect) effects on functional 
outcomes in our model. This could be attributed to two plausible reasons. First, the motor 
sequencing subscale of the NES displayed inadequate internal consistency (α < 0.60) in this 
study, which may attenuate its relationships with other variables in the model.  
Second, a recent study by Ojagbemi et al. (2015) reveals trait marking features for motor 
sequencing NSS whereas motor coordination NSS reflect symptomatic states of the disorder. 
The current results coincide with their results in that the latter but not the former showed 
temporal influences on psychiatric symptoms and functional outcomes over a 6-month period. 
The trait-like features for motor sequencing NSS could explain their lack of relationships 
with the study variables over a relatively short period. Future research should elucidate the 
predictive effects of motor sequencing NSS over a longer follow-up period.  
 
4.3. Limitations 
Several study limitations should be noted. First, the present study included only two 
subscales (motor coordination and sequencing) of the NES and failed to assess participants’ 
NSS in sensory integration. The lack of relevant data is one of the drawbacks of the study. 
Future studies should include assessments on sensory integration NSS to allow a complete 
analysis of the influences of NSS on functional outcomes. Second, our study sample of 
residential patients with chronic schizophrenia may not represent the general patient 
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population well. Further research should attempt to cross-validate the present results among 
first-episode schizophrenia patients. Interestingly, a recent longitudinal study (Chan et al., 
2016) finds no significant difference in NSS between first-episode and chronic schizophrenia 
patients after matching for demographic characteristics.  
Third, despite the longitudinal design, cautions should be warranted to interpret the 
indirect effects as casual since the mediation analysis may not reveal the true casual relation 
(MacKinnon et al., 2007). The fact that functional outcomes were only assessed at 6-month 
follow-up in the present study means that functional outcomes are not necessarily the result 
of NSS and psychiatric symptoms. Randomized intervention studies are more suited to derive 
causal pathways from NSS to functional outcomes in schizophrenia. Besides, a number of 
other important predictors of functional outcomes (Galderisi et al., 2014) such as premorbid 
functioning, memory deficits, coping, and expressed emotions were not included in the 
present model. These determinants could have accounted for part of the unexplained variance 
in functional outcomes in the model. 
 
4.4. Clinical implications 
Though antipsychotic medications are effective in managing psychotic symptoms, they 
have limited long-term effects in improving patients’ negative and disorganized symptoms 
(Buchanan et al., 2009; Remington et al., 2010). According to Leifker and colleagues (2009), 
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functioning outcomes are the product of a complex set of symptoms and neurocognitive 
deficits. The challenge of facilitating functional recovery is more important among 
schizophrenia patients with a chronic course. The present study contributes to a better 
understanding of the determinants of functional outcomes in these schizophrenia patients. 
Our study elucidates the vital role of psychiatric symptoms in mediating the pathways from 
motor coordination NSS to functional outcomes, suggesting them to be additional treatment 
targets in enhancing functional outcomes. Recent studies have suggested that cognitive 
training alone may not be sufficient to achieve functional recovery (Farreny et al., 2013; 
Keshavan et al., 2014; Bhagyavathi et al., 2015) and that NSS may be neurodevelopmental 
markers for schizophrenia disorders (Chan et al., 2016). Integration of NSS assessment into 
screening programs and neuropsychological rehabilitation into standard treatment programs 
could be beneficial for the high-risk, non-remitting schizophrenia patients. 
 
5. Conclusion 
The present study demonstrates that neurological soft signs influence functional 
outcomes indirectly through specific pathways of psychiatric symptoms. Strengths of the 
present study were the longitudinal design with temporal ordering among the predictor, 
mediator, and outcome variables and inclusion of various demographic and clinical 
characteristics as model covariates. Holistic interventions that incorporate pharmacotherapy, 
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psychosocial therapies, and cognitive behavioral interventions should be developed based on 
the individual neurological deficits and needs of the patients. 
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Figure 1. Hypothesized path model on neurological soft signs, psychiatric symptoms and 
functional outcomes in the present study. Note: Pathways for the cascading model are 
denoted by solid lines, whereas the dashed line indicates the direct effects from neurological 
soft signs to functional outcomes. 
 
Figure 2. Unstandardized path coefficients in the cascading path model, with significant 
mediation paths from Time 1 neurological deficits to Time 3 functional outcomes via Time 2 
psychiatric symptoms highlighted in bold and red. Note: Standard errors are shown in 
parentheses. For baseline covariates, only paths that are statistically significant (p < 0.05) are 
displayed. Residual covariances among Time 1 and Time 2 variables are not shown in the 
figure. IADL = Instrumental Activity of Daily Living, ADL = Activity of Daily Living. 
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Table 1 Descriptive statistics of the main study variables (n = 151) 
Variables Range Mean (SD) 
Neurological soft signs (Time 1)   
Motor coordination 0 – 12 4.88 (3.40) 
Sequencing of complex motor acts 0 – 6 4.16 (1.71) 
Psychiatric symptoms (Time 1)   
Positive symptoms 1 – 5.5 1.63 (0.85) 
Negative symptoms 1 – 5.3 2.64 (1.11) 
Disorganized symptoms  1 – 6.7 2.72 (1.32) 
Psychiatric symptoms (Time 2)   
Positive symptoms 1 – 5.3 1.82 (0.83) 
Negative symptoms 1 – 4.8 2.62 (0.91) 
Disorganized symptoms 1 – 6.0 2.76 (0.99) 
Daily functioning (Time 3)   
Instrumental activities of daily living 0 – 5 1.90 (1.42) 
Activities of daily living 20 – 100 96.35 (8.56) 
 
 
Table 2 Bivariate correlations among the main study variables 
 1 2 3 4 5 6 7 8 9 
1. T1 Motor deficit          
2. T1 Sequencing deficit 0.56         
3. T1 Positive symptoms 0.20 0.18        
4. T1 Negative symptoms 0.40 0.33 0.36       
5. T1 Disorganized symptoms 0.49 0.43 0.55 0.56      
6. T2 Positive symptoms 0.25 0.21 0.36 0.10 0.22     
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7. T2 Negative symptoms 0.36 0.21 0.01 0.38 0.18 0.26    
8. T2 Disorganized symptoms   0.48 0.34 0.14 0.27 0.42 0.51 0.58   
9. T3 Instrumental ADL -0.29 -0.25 -0.12 -0.22 -0.35 -0.15 -0.35 -0.40  
10. T3 ADL -0.27 -0.23 -0.11 -0.10 -0.23 -0.45 -0.26 -0.45 0.29 
ADL = Activities of daily living. Correlations with magnitude greater than 0.18 were statistically 
significant at p < 0.01 level. 
 
Table 3 Indirect effects from NSS to functioning outcomes via psychiatric symptoms in the model 
Time 1 NSS Time 2 Psychiatric 
symptoms 
Time 3 
Outcome 
Indirect 
effect 
BC bootstrap  
95% CI 
Motor deficit Positive  IADL 0.01 -0.01 to 0.03 
 Negative   -0.02* -0.05 to -0.01 
 Disorganized   -0.05* -0.10 to -0.02 
     
Sequencing deficit Positive  IADL 0.00 -0.01 to 0.04 
 Negative   0.01 -0.02 to 0.04 
 Disorganized   -0.01 -0.07 to 0.04 
     
Motor deficit Positive  ADL -0.22* -0.77 to -0.04 
 Negative   0.04 -0.06 to 0.27 
 Disorganized   -0.24* -0.83 to -0.06 
     
Sequencing deficit Positive  ADL -0.09 -0.55 to 0.10 
 Negative   -0.01 -0.26 to 0.04 
 Disorganized   -0.04 -0.44 to 0.14 
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BC bootstrap 95% CI = Bias-corrected bootstrap 95% confidence interval. ADL = Activities of daily 
living; IADL = Instrumental activities of daily living. *Significant indirect effects with the bootstrap 
95% CI excluding zero. 
Highlights 
 Path analysis evaluated direct and indirect effects of NSS on functional outcomes via 
psychiatric symptoms 
 Motor coordination and sequencing NSS did not have significant direct effects on 
functional outcomes 
 Motor coordination NSS exerted negative indirect effects on functional outcomes via 
psychiatric symptoms  
 The current results contribute to a better understanding of the determinants of 
functional outcomes  
 That motor sequencing NSS did not affect functional outcomes may be explained by 
the trait marking features 
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